Symptom-centric view
Injection site erythema
Substances reporting Injection site erythema disproportionately — ranked by ROR.
showing 2 of 2
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tirzepatide Mounjaro · Zepbound | 6.2 [6.0–6.3] | 4,771 | glp-1 | new |
| 2.6 [2.4–2.9] | 384 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).